Expertise in
2
conditions

Tie Chong

No. 157, West Five Road, 
Xi'an, CN 
Expertise in
2
conditions
No. 157, West Five Road, 
Xi'an, CN 

Overview

Tie Chong practices practicing medicine in Xi'an, China.

Chong is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Renal Cell Carcinoma (RCC), Urethral Stricture, Prostate Cancer, Nephrectomy, and Sacral Nerve Stimulation.

They are actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 1 clinical trial.

Locations

No. 157, West Five Road, Xi'an, 710000, China
Other Locations
No. 157 Xiwu Road, Xi'an, 710004, China
157 West Fifth Road, Xi'an, 710000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2024
Intervention Type: Drug
Study Drug: Fuzuloparib+Abiraterone Acetate+Prednisone
Study Phase: Phase 3

130 Total Publications

Defining a hilar "danger zone" to guide surgical decision-making in T1 renal cell carcinoma.
Defining a hilar "danger zone" to guide surgical decision-making in T1 renal cell carcinoma.
Journal: Urologic oncology
Published: May 08, 2026

Frequently Asked Questions about Tie Chong

Is Tie Chong a top-rated expert for Renal Cell Carcinoma (RCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Tie Chong is classified as an Distinguished expert for Renal Cell Carcinoma (RCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tie Chong participate in research or clinical trials?

Yes. Tie Chong has published 130 articles and abstracts on conditions like Renal Cell Carcinoma (RCC). You can view a list of Tie Chong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chong's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile